Ipilimumab vs Perindopril Erbumine
Ipilimumab vs Perindopril Erbumine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Perindopril Erbumine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Perindopril Erbumine — Small molecule.